Medpace Holdings Net Worth

Medpace Holdings Net Worth Analysis

Medpace Holdings Target Price Consensus

Medpace Holdings Target Price Projection

Medpace Holdings' current and average target prices are 323.50 and 300.30, respectively. The current price of Medpace Holdings is the price at which Medpace Holdings is currently trading. On the other hand, Medpace Holdings' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Medpace Holdings and the information provided on this page.

Know Medpace Holdings' Top Institutional Investors

Note, although Medpace Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Medpace Holdings' market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.3 B.

Project Medpace Holdings' profitablity

The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Medpace Holdings' management efficiency

Medpace Holdings has return on total asset (ROA) of 0.1545 % which means that it generated a profit of $0.1545 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.6583 %, meaning that it created $0.6583 on every $100 dollars invested by stockholders. Medpace Holdings' management efficiency ratios could be used to measure how well Medpace Holdings manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/14/2025, Return On Tangible Assets is likely to grow to 0.30. Also, Return On Capital Employed is likely to grow to 0.47. At this time, Medpace Holdings' Total Current Liabilities is relatively stable compared to the past year. As of 07/14/2025, Non Current Liabilities Total is likely to grow to about 178 M, while Liabilities And Stockholders Equity is likely to drop slightly above 1.4 B.

Medpace Holdings Corporate Filings

Medpace Holdings time-series forecasting models is one of many Medpace Holdings' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medpace Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Medpace Holdings Earnings Estimation Breakdown

The calculation of Medpace Holdings' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Medpace Holdings is estimated to be 2.99 with the future projection ranging from a low of 2.76 to a high of 3.28. Please be aware that this consensus of annual earnings estimates for Medpace Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.

Medpace Holdings Earnings Projection Consensus

Medpace Holdings Earnings per Share Projection vs Actual

Actual Earning per Share of Medpace Holdings refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Medpace Holdings predict the company's earnings will be in the future. The higher the earnings per share of Medpace Holdings, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Medpace Holdings Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Medpace Holdings, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Medpace Holdings should always be considered in relation to other companies to make a more educated investment decision.

Medpace Quarterly Analyst Estimates and Surprise Metrics

Medpace Holdings Corporate Management

Additional Tools for Medpace Stock Analysis